Retinyl palmitate

SKU: orb1309911

Description

Retinyl palmitate, a stable ester form of vitamin A, is a naturally occurring compound investigated for its potential chemopreventive and anticancer properties. Research applications include in vitro studies on cell differentiation and proliferation, as well as in vivo models exploring its role in cancer prevention and dermatology.

Research Area

Metabolism Research

Key Properties

• CAS Number: 79-81-2
• MW: 524.86
• Purity: 70.00%
• Formula: C₃₆H₆₀O₂
• SMILES: CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C
• Target: Endogenous Metabolite
• Solubility: DMSO:50 mg/mL (95.26 mM)

Bioactivity

• In Vivo:
  Vitamin A Palmitate (80 mg/kg daily p.o.) or (800 mg/kg once a week p.o.) dose-dependently decrease the size of papillomas in mice the daily administration induces a somewhat higher extent of regression tha the weekly application in the total doses are compared. Water miscible solutions of Vitamin A Palmitate as well as of Vitamin A acid given b the oral route elici the same effect on papillomas. Vitamin A Palmitate (A Single simultaneous injection of 150 g) enhances cell-mediated immunity to sheep red blood cells(SRBC) as early as 3 days following immunization, an the enhancement persists for at least 3 weeks.
• In Vitro:
  The microencapsulation of vitamin A palmitate by gelatin-acacia complex is a promising method for converting an oily vitamin to solid powders for an aid to andling and ease of incorporation in preparations.

Storage & Handling

• Storage: keep away from direct sunlight | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Disclaimer: For research use only

Alternative Names

Retinyl, Retinyl (Vitamin A) Palmitate, Retinol, Retinol palmitate, Retinyl palmitate, Vitamin A, Vitamin A palmitate, inhibit, EndogenousMetabolite, Inhibitor, Endogenous Metabolite

Compound Identifiers

PubChem CID

5280531